The findings support adopting F-18 DCFPyL PET/CT as the standard of care for prostate cancer staging, authors of a new Scientific Reports paper concluded.
Difficulty obtaining PET/CT scans was reported by 55% of respondents, with 21% citing this as the greatest barrier in treating classic Hodgkin lymphoma.
That’s according to an award-winning scientific online poster presented this week during the American Roentgen Ray Society’s annual meeting being held in Honolulu, Hawaii.
Features pertaining to location, density and superimposed structures were recently found to be associated with poorer outcomes for patients who initially had their lung cancer overlooked on radiographs.
The AUC includes a total of 32 clinical scenarios that have been grouped into four categories of cancer: breast, skin, cancer of other sites and lymphedema.
Men with prostate cancer can avoid many of the unpleasant side effects of chemo, surgery and radiation therapy when they are treated with high-intensity focused ultrasound instead.
Salvage radiation therapy guidelines for patients with prostate cancer recurrence need to be updated to include findings identified on PSMA PET, according to new research shared at SNMMI’s annual conference this week.
The Detroit-based cancer institute achieved this landmark moment using the MRIdian A3i, which is the latest enhancement of the MRIdian system from ViewRay, Inc.
"The present study validated the feasibility of using MRI-based radiomics to identify a disease prone to missed diagnosis and misdiagnosis," experts involved in the study said.
Providers screening women with dense breasts and benign breast disease should consider individualized mammogram protocols for these patients, authors of the study suggested.
For 45% to 47% of patients who were deemed negative after conventional baseline scans, the use of the radiohybrid imaging agent resulted in at least one true positive PET finding
